STOCK TITAN

Autonomix Medical posts updated corporate presentation

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Autonomix Medical, Inc. (AMIX) posted an updated corporate presentation on its official website on November 20, 2026. The presentation is furnished under Regulation FD and is not treated as filed under the Exchange Act or Securities Act, or incorporated by reference in another filing, unless specifically identified for incorporation.

Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Regulation FD regulatory
"Item 7.01. Regulation FD Disclosure"
Regulation FD is a rule that prevents company insiders, like executives, from sharing important information with some people before others get it. It matters because it helps ensure all investors have equal access to key news, making the stock market fairer and reducing chances of insider trading.
incorporated by reference regulatory
"nor shall it be incorporated by reference in any filing"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001617867 0001617867 2026-11-20 2026-11-20
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): November 20, 2026
 
 
amixlogo.jpg
 
 
Autonomix Medical, Inc.
(Exact name of registrant as specified in its charter)
 
 
Delaware
001-41940
47-1607810
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
 
21 Waterway Avenue, Suite 300
The Woodlands, TX 77380
(Address of principal executive offices) (Zip Code)
 
Registrant’s telephone number, including area code: (713) 588-6150
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class
Trading Symbol(s)
Name of Each Exchange on which Registered
Common Stock, par value $0.001 per share
AMIX
The Nasdaq Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☒
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.               ☐
 

 
Item 7.01. Regulation FD Disclosure
 
On November 20, 2026, the Company posted an updated corporate presentation set forth as Exhibit 99.1 herein on the Company’s official website.
 
The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be “filed” for the purpose of the Securities Exchange Act of 1934, as amended (“Exchange Act”), nor shall it be incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (“Securities Act”), unless specifically identified therein as being incorporated by reference.
 
Item 9.01.  Financial Statements and Exhibits
 
 
(d) Exhibits
 
 
 
 
 
Exhibit No.
Description
 
99.1
Investor Presentation dated November 2026
 
104
Cover page Interactive Data File (formatted as Inline XBRL document)
 
 
Signature
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
AUTONOMIX MEDICAL, INC.
 
 
 
 
 
 
 
 
 
 
By:
/s/ Trent Smith                      
 
 
 
Trent Smith
 
 
 
Chief Financial Officer
 
 
 
Dated: November 20, 2026
 

Exhibit 99.1

 

slide01.jpg

 

 


 

slide02.jpg

 

 


 

slide03.jpg

 

 


 

slide04.jpg

 

 


 

slide05.jpg

 

 


 

slide06.jpg

 

 


 

slide07.jpg

 

 


 

slide08.jpg

 

 


 

 

slide09.jpg

 

 


 

slide10.jpg

 

 


 

 

slide11.jpg

 

 


 

slide12.jpg

 

 


 

slide13.jpg

 

 


 

slide14.jpg

 

 


 

slide15.jpg

 

 


 

slide16.jpg

 

 


 

 

slide17.jpg

 

 

Filing Exhibits & Attachments

5 documents

Keep reading